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Abstract
Background: At least three different EV-71 subgenotypes were identified from an outbreak in
Malaysia in 1998. The subgenotypes C2 and B4 were associated with the severe and fatal infections,
whereas the B3 virus was associated with mild to subclinical infections. The B3 virus genome
sequences had ≥85% similarity at the 3' end to CV-A16. This offers opportunities to examine if
there are characteristic similarities and differences in virulence between CV-A16, EV-71 B3 and EV-
71 B4 and to determine if the presence of the CV-A16-liked genes in EV-71 B3 would also confer
the virus with a CV-A16-liked neurovirulence in mice model infection.
Results: Analysis of human enterovirus 71 (EV-71) subgenotype B3 genome sequences revealed
that the 3D RNA polymerase and domain Z of the 3'-untranslating region RNA secondary
structure had high similarity to CV-A16. Intracerebral inoculation of one-day old mice with the
virus resulted in 16% of the mice showing swollen hind limbs and significantly lower weight gain in
comparison to EV-71 B4-infected mice. None of the mice presented with hind leg paralysis typical
in all the CV-A16 infected mice. CV-A16 genome sequences were amplified from the CV-A16-
infected mice brain but no amplification was obtained from all the EV-71-inoculated mice suggesting
that no replication had taken place in the suckling mice brain.
Conclusion: The findings presented here suggest that EV-71 B3 viruses had CV-A16-liked non-
structural gene features at the 3'-end of the genome. Their presence could have affected virulence
by affecting the mice general health but was insufficient to confer the EV-71 B3 virus a CV-A16-
liked neurovirulence in mice model infection.
Background
Enterovirus 71 (EV-71) was first described in 1969 during
an outbreak with central nervous system complications in
California [1]. Since then, EV-71 infections have been
associated with a number of outbreaks with wide clinical
manifestations, ranging from mild hand, foot and mouth
disease (HFMD) to severe neurological complications and
deaths. These include outbreaks in Bulgaria [2], Hungary
[3], Japan [4] and more recently Malaysia [5,6], Taiwan
[7] and Singapore [8]. In the later three outbreaks, more
than a hundred deaths in total were reported, elevating
EV-71 infection as one of the most deadly virus infection
to date amongst young children below the age of 3 years
old in Asia. The sudden emergence of the deadly forms of
EV-71 infection in Asia was puzzling, as the virus together
with other human enterovirus A viruses especially
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been noted to cause HFMD in the region for sometime
[9]. During the outbreak in Malaysia, at least three differ-
ent EV-71 subgenotypes were identified. The subgeno-
types C2 and B4 were associated with the severe and fatal
infections, whereas, mild to subclinical infections were
associated with the B3 viruses [10-12]. Unlike the earlier
two subgenotypes, the B3 virus circulated for only a brief
period during the outbreak and they have since not been
isolated from patients from the later outbreaks [11,12]. A
recent study reported that the B3 virus genome sequences
had ≥93% similarity to EV-71 at the 5' end whereas the P3
genome region and 3'UTR had ≥85% similarity to CV-A16
[13]. CV-A16 is known to be the most common causative
agent for the self-limiting HFMD. It is usually character-
ized by mild fever, oral ulcers and vesicular lesions on
palms and soles and is not known to cause severe and fatal
CNS infections. It is not presently understood why EV-71
infections tend to cause the more severe form of HFMD in
comparison to CV-A16. The findings that EV-71 B3 viruses
had high sequence similarity to CV-16 at the 3' end of the
genome and that the viruses were not associated with the
severe form of HFMD, offered opportunities to examine
the potential roles of the respective genes in determining
virulence. Hence, the present study was undertaken to
examine if there are characteristic similarities and differ-
ences between CV-A16, EV-71 B3 and the more virulent
EV-71 B4 virus and to determine if the presence of the CV-
A16-liked genes in the EV-71 B3 virus genome would also
confer the virus a CV-A16-liked neurovirulence in mice.
Results and Discussion
The consensus amino acid sequences of the two available
EV-71 B3 virus genomes (SHA63 and SHA66) were com-
pared to other available subgenotype B4 and CV-A16/G10
genome sequences from the Genbank. Several amino
acids (His1775, Thr1947, Ile1806, Gln1825, Thr1928, Thr1947,
Asn2099, Glu2114 and Gln2159) that were characteristic of
the CV-A16/G10 were found in EV-71 B3 isolates. These
amino acid differences occurred only within the 3D RNA
polymerase gene, suggesting that this gene is very much
CV-A16 than it is EV-71. Comparisons of the EV-71 B3
amino acid sequences against all other EV-71 and CV-A16
also revealed at least 12 amino acids (Asn1124, Arg1152,
Ser1335, Ser1641, Tyr1799, Asp1822, Val1860, Ser1864, Val1997,
Ala2039 Asp2101 and Leu2125) that were unique to the EV-71
B3 isolates. Eight of these amino acid differences occurred
within the 3D RNA polymerase gene. Two of these unique
mutations found were located between amino acids 176–
348 genome region essential for RNA-protein interactions
[14] (Fig. 1). Alignment of the EV-71 B3 (SHA66) and EV-
71 B4 (UH1) isolates RNA polymerase against the three-
dimensional crystal structure of poliovirus 1 Mahoney
strain 3D RNA polymerase (PDB: 1RDR) was performed
to locate these mutations. Of these eight mutations in EV-
71 B3 virus, three were located within the finger sub-
domain and two were located at the palm motif suggest-
ing that the EV-71 B3 virus amino acid substitutions were
mainly located within the 3D RNA polymerase functional
domains. The highly 'flexible' finger domain is involves in
modulating substrate recognition and oligomerization of
the polymerase for binding to nucleotides [15]. In polio-
virus, mutations within the 3D RNA polymerase located
to the 3' end of the genome have been shown to affect
neurovirulence [16,17]. Hence, this highlights the poten-
tial importance of the 3D RNA polymerase in determining
the virus neurovirulence. It was also found that in addi-
tion to the presence of CV-A16 or CV-A16-liked 3D RNA
polymerase gene sequences, the EV-71 B3 viruses also
shared a similar predicted 3' UTR secondary structures
with CV-A16/G10 at domain Z (Fig. 2), a domain
reported as important in determining cardiovirulence of
CV-B3 [18]. Mutations that affect the stem-and-loop struc-
tures have been shown earlier to abolish infectivity and
virus RNA synthesis [19,20]. The predicted domain Y
known to form a tertiary RNA 'kissing' structure with
domain X of the EV-71 B3 virus, however, differed from
the EV-71 B4 and CV-A16/G10 (Fig. 2).
Inoculation of one day-old newborn mice showed that all
mice inoculated with CV-A16 had the typical signs and
symptoms of CV-A16 infections by day two post-inocula-
tion. The mice were lethargic, had floppy tails, tremoring,
uncoordinated movement and reduced average body
weight in comparison to EV-71 B3- or EV-71 B4-inocu-
lated mice (Fig. 3a,3g). Approximately 17% (4/24) of the
mice had hind leg paralysis by day three post-inoculation
and one died (Fig. 3b,3e,3f, Additional file: 1). By day
four post-inoculation, all the CVA16-inoculated mice had
developed hind leg paralysis and subsequently died (Fig.
3b,3e,3f). A 150 bp enterovirus genome sequence were
amplified and sequenced from the total RNA of the brain
of all the CV-A16-inoculated mice confirming the pres-
ence of CV-A16 in the mice brain (Fig. 4). Mice-inoculated
with EV-71 B3 and EV-71 B4 viruses also had significantly
reduced average body weight in comparison to the control
mock-infected mice (Student's t-test, P < 0.05, Fig. 3d,3g).
Mice inoculated with EV-71 B3 virus, however, had signif-
icantly reduced average body weight in comparison to
those inoculated with the EV-71 B4 virus (Fig. 3g). These
mice appeared lethargic and uncoordinated beginning on
day two post-inoculation. Of these, 16% (4/25) devel-
oped swollen hind legs and one subsequently died on day
five post-inoculation (Fig. 3c,3e,3f). There were no hind
leg paralysis noted and the remaining surviving mice
recovered, fed well and regained balance after day six post-
inoculation. In contrast, about 20% (6/31) of the mice
inoculated with EV-71 B4 virus developed swollen fore
limbs or hind legs and of these, three died after day four
post-inoculation (Fig. 3e,3f). After day eight post-inocula-Page 2 of 7
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active and fed well. Pairwise comparison of the clinical ill-
ness and survival probability between the virus-inocu-
lated groups and control were significant suggesting that
the three viruses, CV-A16, EV-71 B3 and EV-71 B4 viruses
caused death in mice (log rank survival analysis, P < 0.05,
Fig. 3e,3f) but only infection with CV-A16 lead to 100%
mortality. In contrast to CV-A16 infection, no amplifica-
tion of the enterovirus sequence was detected in the
selected EV-71 B4- and EV-71 B3-inoculated mice brain,
suggesting that EV-71 B3 and EV-71 B4 viruses perhaps
did not replicate in the mice brain when introduced
intracerebrally (Fig. 4). This may help to explain the
absence of hind leg paralysis in all the EV-71-infected
mice and the complete recovery of all the surviving mice.
Death seen amongst these mice may have been caused by
infection of other tissues as manifested in mice with swol-
len limbs and legs. Evidence suggesting that EV-71 strains
isolated during the Bulgaria poliomyelitis-like epidemic
had higher tropism for mouse muscle tissues than the
brain tissues [2] and EV-71 neurovirulence mimicking
human infection was achieved only from using a mouse-
adapted virus strain but not the parental strain [21,22]
support the findings from the present study that EV-71 B3
and B4 did not infect the brain. The infection, however,
manifests clinically in some mice as non-specific swollen
limbs and legs. Hence it is possible that, though both EV-
71 and CV-A16 viruses are closely related, different recep-
tors are utilize for the respective virus entry into the differ-
ent tissues and this could be mediated through the virus
structural proteins. The mutations that occurred within
the 3D RNA polymerase of the EV-71 B3 virus along with
the presence of CV-A16-liked 3' UTR domain Z RNA sec-
ondary structure then could contribute to virulence but by
themselves did not affect EV71 neurovirulence in mice as
in contrast to CV-A16, the B3 virus lacks tropism for the
mice brain. Since the major differences between the EV-71
B4 and EV-71 B3 viruses occurred at the 3' end of the
genome, this support the view that the structural genes of
EV-71 and CV-A16 determined tissue tropisms.
Results from the present study, also did not support the
possibility that acquisition of CV-A16-liked genome
sequences alone is sufficient to confer the EV-71 B3 virus
Structural alignment of EV-71 and CV-A16 3D RNA polymerase amino acid sequencesFigure 1
Structural alignment of EV-71 and CV-A16 3D RNA polymerase amino acid sequences. EV-71 subgenotype B3, B4 and CV-
A16/G10 amino acid sequences were aligned against the poliovirus 1 Mahoney 3D RNA polymerase template sequences (PDB: 
1RDR). Conserved residues are indicated as (●) and each domain are boxed and labeled. Residues shared by EV-71 B3 virus 
and CV-A16 were highlighted in grey and residues unique for EV-71 B3 virus were highlighted in pink.Page 3 of 7
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mice weight gain differences noted between mice infected
with EV-71 B3 and EV-71 B4 viruses, with the later per-
forming much better, however, suggested that EV-71 B3
virus infection somehow did affect mice general health. As
weight gain differences are the only biological parameter
that differentiate between the B3 and B4 viruses, it does
appears that EV-71 B3 affected mice more than the EV-71
B4 virus. It is also worth noting that in contrast to infec-
tion in mice, CV-A16 infection in human in general does
not result in severe infection as oppose to EV-71, particu-
larly the EV-71 B4 virus infection. In parallel manner, the
EV-71 B3 viruses, while they affected mice, they did not
cause severe or fatal infection in humans. These implied
that the EV-71 B3 virus is truly different and as its genome
suggested, it has to some extent features of both EV-71
and CV-A16 infection in-vivo.
Conclusion
Results from the present study suggest that EV-71 B3 virus
had CV-A16-liked non-structural gene 3D RNA polymer-
ase and 3' UTR features at the 3' end of the genome. Their
presence affected virulence differently from infection with
EV-71 B4 and CV-A16 by affecting the mice general
health. The presence of the CV-A16-liked genes, however,
was insufficient to markedly influence the neurovirulence
properties of EV-71 B3 virus in mice.
Materials and methods
Viruses
Two EV-71 isolates identified from the 1997 HFMD out-
break in Malaysia were used. The subgenotype B3 isolate,
SHA66 (EMBL: AJ238457) was isolated from a HFMD
patient presented with mild infection [6,23]. The subgen-
otype B4 isolate, UH1 (EMBL: AJ238455) on the other
hand, was isolated from the brain of a patient who died of
EV-71-associated neurogenic pulmonary edema [5,6,24].
The CV-A16 isolate used was previously isolated from a
HFMD patient seen at the University Malaya Medical Cen-
tre. This CV-A16 isolate was identified and characterized
using monoclonal antibody staining (Chemicon Cat
#3323, California, USA) and amplification of partial 5'
UTR gene (data not shown).
Amino acid sequence analysis
Amino acid sequences were examined after stripping the
5' UTR and 3' UTR sequences and consensus sequences of
EV-71 B3 and EV-71 B4 viruses were aligned and manu-
ally edited using GeneDoc software [25]. The previously
published three-dimensional crystal structure of the 3D
RNA polymerase was downloaded as template for the
alignment. Using the WHAT IF program [26], domains
that represent the conserved regions, loops, insertion or
deletions were manually visualized to generate a struc-
tural alignment.
Predicted RNA secondary structures of EV-71 B3, EV-71 B4 and CV-A16/G10 3' UTRFigure 2
Predicted RNA secondary structures of EV-71 B3, EV-71 B4 
and CV-A16/G10 3' UTR. RNA structures were predicted 
based on the lowest free energy, using the Zuker algorithm 
as implemented in RNA Structure (version 3.71). The pre-
dicted 3' UTR structures consisted of nucleotides from posi-
tion 7326–7407 and additional 12 nucleotides of the poly-A 
tail.Page 4 of 7
(page number not for citation purposes)
Virology Journal 2005, 2:74 http://www.virologyj.com/content/2/1/74RNA secondary structure prediction
The 3' UTR RNA secondary structure was predicted using
Zuker optimal and suboptimal minimal free energy fold-
ing algorithms, as implemented in RNA Structure version
3.71 software [27]. Part of the poly A tract was incorpo-
rated into the sequences.
EV-71 and CV-A16 infections of newborn miceFigure 3
EV-71 and CV-A16 infections of newborn mice. One-day old newborn mice were intracerebrally inoculated with 1 × 103 PFU 
virus per mouse and monitored daily. CV-A16-infected mice had floppy tails on day two post-inoculation (a) and hind leg paral-
ysis beginning on day three post-inoculation (arrow, b). Mice with swollen limbs were noted in EV-71 B3 virus infection (arrow, 
c) and the EV-71 B3-infected mice had significantly reduced body weight gain in comparison to the mock-infected mice (d, V = 
B3-infected mouse, C = mock-infected mouse). Mice with floppy tails, swollen limbs and paralysis (e) and death (f) were 
recorded. The weight gain of the surviving mice was also determined (g).Page 5 of 7
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A total of 24, 25 and 31 one-day old newborn ICR mice
were inoculated intracerebrally with either CV-A16 or
SHA66 (B3 virus) or UH1 (B4 virus) virus inoculum. The
virus inoculum with infectivity of ~1 × 103 p.f.u. was
injected in a volume of 10–20 µl into the mice brain. The
mice were closely monitored for any clinical symptoms,
paralysis and death and the weight of each surviving
mouse was recorded daily up to day 11 post-inoculation.
Another litter with at least 10 one-day old newborn mice
was injected with comparable growth medium and used
as controls. At selected intervals post-infection, some of
the mice were sacrificed and the brain tissues were har-
vested for total RNA using the TRI Reagent™ (Molecular
Research Centre, Inc., Cincinnati, USA) following the
manufacturer's recommended protocols. The RT-PCR
amplification for the detection of enterovirus sequence
was performed using 1 µg of RNA. Access RT-PCR kit
(Promega, USA) and primer pairs, EntabF (5'-TCC TCC
GGC CCC TGA ATG CGG CTA AT-3'; nucleotide positions
449–474, based on MS87 strain, Genbank: U22522) and
EVRR (5'-AAT TGT CAC CAT AAG CAG GC-3'; nucleotide
positions 586–606) were used. Reverse transcription was
performed at 42°C for an hour followed by amplification
steps; 95°C-30 seconds, 55°C-30 seconds and 72°C-30
seconds for 30 cycles and finally with 5 minutes extension
at 72°C using the PTC thermal cycler (MJ Research, Mas-
sachusetts, USA). When no amplicon was obtained, the
number of cycle was increased to 40. Alternatively, a sec-
ond step PCR using similar parameters was performed
using ten-fold diluted RT-PCR product as template. The
amplified DNA fragments were electrophoresed using 2%
agarose gel in 0.5 × tris-acetate EDTA buffer (0.02 M Tris
base, 0.5 mM EDTA pH 8.0, 0.057% glacial acetic acid)
and sequence confirmation was made by sequencing the
DNA fragment.
Statistics
Student's t-test was used to evaluate if the differences in
weight between the virus-inoculated mice and control
mice was significant. Wilcoxon signed rank test was used
to compare the survival and paralysis probability between
the virus-inoculated mice and control mice. All statistical
analyses were implemented using SPSS for Windows ver-
sion 11.5 (SPSS Inc., Illinois, USA). All tests were two-
sided and P < 0.05 was considered as statistically
significant.
List of Abbreviation
CV Coxsackievirus
EV Enterovirus
HFMD Hand, foot and mouth disease
UTR Untranslated region
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
The corresponding author, Sazaly AbuBakar is the princi-
pal investigator of the study; is involved in the design,
Detection of enterovirus genome sequences in infected newborn mice brainFigure 4
Detection of enterovirus genome sequences in infected newborn mice brain. At selected intervals post-inoculation (indicated 
by the number above each lane), mice were sacrificed (each mouse indicated by the alphabet above each lane) and RT-PCR was 
performed using an enterovirus specific primers. The presence of a 150 bp amplified DNA fragment indicates the presence of 
enterovirus genome, which was later confirmed by DNA sequencing.Page 6 of 7
(page number not for citation purposes)
Virology Journal 2005, 2:74 http://www.virologyj.com/content/2/1/74Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
supervision, data analyses and writing of the report. Chan
Y-F performed all the virological investigations, nucle-
otide sequencing and analyses of data. All authors were
involved in the preparation of this "Research Article" and
figures.
Additional material
Acknowledgements
This study is funded in parts by grants from the Ministry of Science, Tech-
nology and Innovation, Malaysia # 06-02-09-001-BTK/TD/002.
References
1. Schmidt NJ, Lennette EH, Ho HH: An apparently new enterovi-
rus isolated from patients with disease of the central nervous
system.  J Infect Dis 1974, 129:304-309.
2. Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L,
Koroleva G, Vasilenko S, Brodvarova I, Nikolova M, Gyurova S,
Gacheva M, Mitov G, Ninov N, Tsylka E, Robinson I, Frolova M,
Bashkirtsev V, Martiyanova L, Rodin V: Enterovirus 71 isolated
from cases of epidemic poliomyelitis-like disease in Bulgaria.
Arch Virol 1979, 60:329-340.
3. Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I: Virological diagno-
sis of enterovirus type 71 infections: experiences gained dur-
ing an epidemic of acute CNS diseases in Hungary in 1978.
Arch Virol 1982, 71:217-227.
4. Hagiwara A, Yoneyama T, Takami S, Hashimoto I: Genetic and phe-
notypic characteristics of enterovirus 71 isolates from
patients with encephalitis and with hand, foot and mouth
disease.  Arch Virol 1984, 79:273-283.
5. Lum LCS, Wong KT, Lam SK, Chua KB, Goh AYT, Lim WL, Ong BB,
Paul G, AbuBakar S, Lambert M: Fatal enterovirus 71
encephalomyelitis.  J Pediatr 1998, 133:795-798.
6. AbuBakar S, Chee HY, Al-Kobaisi MF, Xiaoshan J, Chua KB, Lam SK:
Identification of enterovirus 71 isolates from an outbreak of
hand, foot and mouth disease (HFMD) with fatal cases of
encephalomyelitis in Malaysia.  Virus Res 1999, 61:1-9.
7. Wu TN, Tsai SF, Li SF, Lee TF, Huang TM, Wang ML, Hsu KH, Shen
CY: Sentinel surveillance for Enterovirus 71, Taiwan, 1998.
Emerg Infect Dis 1999, 5:458-460.
8. Singh S, Chow VTK, Chan KP, Ling AE, Poh CL: RT-PCR, nucle-
otide, amino acid and phylogenetic analyses of enterovirus
type 71 strains from Asia.  J Virol Meth 2000, 88:193-204.
9. Infectious agent surveillance report (IASR). Isolation and
detection report of viruses by years 1982–July 2005: entero-
virus 1 & enterovirus 2   [http://idsc.nih.go.jp/iasr/virus/virus-
kk.html]
10. McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ:
Phylogenetic analysis of enterovirus 71 strains isolated dur-
ing linked epidemics in Malaysia, Singapore, and Western
Australia.  J Virol 2001, 75:7732-7738.
11. Cardosa MJ, Perera D, Brown BA, Cheon D, Chan HM, Chan KP, Cho
H, McMinn P: Molecular epidemiology of human enterovirus
71 strains and recent outbreaks in the Asia-Pacific region
comparative analysis of the VP1 and VP4 genes.  Emerg Infect
Dis 2003, 9:461-468.
12. Herrero LJ, Lee CSM, Hurrelbrink RJ, Chua BH, Chua KB, McMinn
PC: Molecular epidemiology of enterovirus 71 in peninsular
Malaysia, 1997–2000.  Arch Virol 2003, 148:1369-1385.
13. Chan YF, AbuBakar S: Recombinant human enterovirus 71 in
hand, foot and mouth disease patients.  Emerg Infect Dis 2004,
10:1468-1470.
14. Cornell CT, Semler BL: Subdomain specific functions of the
RNA polymerase region of poliovirus 3CD polypeptide.  Virol-
ogy 2002, 298:200-213.
15. Hansen JL, Long AM, Schultz SC: Structure of the RNA-depend-
ent RNA polymerase of poliovirus.  Structure 1997, 5:1109-1122.
16. Christodoulou C, Colbere-Garapin F, Macadam A, Taffs LF, Marsden
S, Minor P, Horaud F: Mapping of mutations associated with
neurovirulence in monkeys infected with Sabin 1 poliovirus
revertants selected at high temperature.  J Virol 1990,
64:4922-4929.
17. Tardy-Panit M, Blondel B, Martin A, Tekaia F, Horaud F, Delpeyroux
F: A mutation in the RNA polymerase of poliovirus type 1
contributes to attenuation in mice.  J Virol 1993, 67:4630-4638.
18. Merkle I, van Ooij MJ, van Kuppeveld FJ, Glaudemans DH, Galama JM,
Henke A, Zell R, Melchers WJ: Biological significance of a human
enterovirus B-specific RNA elements in the 3' nontranslated
region.  J Virol 2002, 76:9900-9909.
19. Melchers WJ, Hoenderop JG, Bruins Slot HJ, Pleij CW, Pilipenko EV,
Agol VI, Galama JM: Kissing of the two predominant hairpin
loops in the coxsackie B virus 3' untranslated region is the
essential structural feature of the origin of the replication
required for the negative-strand RNA synthesis.  J Virol 1997,
71:686-696.
20. Mirmomeni MH, Hughes PJ, Stanway G: An RNA tertiary struc-
ture in the 3' untranslated region of enteroviruses is neces-
sary for efficient replication.  J Virol 1997, 71:2363-2370.
21. Chen YC, Yu CK, Wang YF, Liu CC, Su IJ, Lei HY: A murine oral
enterovirus 71 infection model with central nervous system
involvement.  J Gen Virol 2004, 85:69-77.
22. Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR,
Yeh TM, Chen SH, Yu CK: A mouse-adapted enterovirus 71
strain causes neurological disease in mice after oral
infection.  J Virol 2004, 78:7916-7924.
23. AbuBakar S, Chee HY, Shafee N, Chua KB, Lam SK: Molecular
detection of enteroviruses from an outbreak of hand, foot
and mouth disease in Malaysia in 1997.  Scand J Infect Dis 1999,
31:331-335.
24. AbuBakar S, Shafee N, Chee HY: Induction of apoptosis in neu-
rogenic pulmonary edema.  Med J Malaysia 1999, 54:402-403.
25. Nicholas KB, Nicholas HB Jr, Deerfield DW: GeneDoc: analysis
and visualization of genetic variation.  EMBNEW NEWS 1997,
4:14.
26. Vriend G: WHAT IF: A molecular modeling and drug design
program.  J Mol Graph 1990, 8:52-56.
27. Matthews DH, Sabina J, Zuker M, Turner DM: Expanded sequence
dependence of thermodynamic parameters improves pre-
diction of RNA secondary structure.  J Mol Biol 1999,
288:911-940.
Additional File 1
Hind leg paralysis in CV-A16 infected mice. By day three post-inocula-
tion, the mice were lethargic, tremoring and uncoordinated.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1743-
422X-2-74-S1.wmv]Page 7 of 7
(page number not for citation purposes)
